Robin Lewis Jones (@robinl_jones) 's Twitter Profile
Robin Lewis Jones

@robinl_jones

Head of #Sarcoma Unit at @royalmarsdenNHS. Team Leader of Sarcoma Trials for @ICR_London. All personally tweeted views are my own.

ID: 740586055959728129

linkhttps://www.royalmarsden.nhs.uk/our-consultants-units-and-wards/consultant-directory/dr-robin-jones calendar_today08-06-2016 16:47:29

2,2K Tweet

2,2K Followers

2,2K Following

Charlotte Brierley (@ckbrierley) 's Twitter Profile Photo

🚨🚨Paper out! 🚨🚨 Delighted to share our work, now published in Nature Genetics 🧬! shorturl.at/94s5S We identified a targetable, chromothripsis-associated genetic event in blast phase (BP) MPN, a particularly poor prognostic subtype of acute leukaemia. 1/n 🧵👇

🚨🚨Paper out! 🚨🚨
Delighted to share our work, now published in <a href="/NatureGenet/">Nature Genetics</a> 🧬! shorturl.at/94s5S

We identified a targetable, chromothripsis-associated genetic event in blast phase (BP) MPN, a particularly poor prognostic subtype of acute leukaemia. 1/n

🧵👇
CTOS (@ctosociety) 's Twitter Profile Photo

We're launching a new series #fromCTOStoSUCCESS to highlight papers based on data presented at #CTOS2024! 🚨New benchmark values for outcomes of comprehensive resection of retroperitoneal liposarcoma! Great effort by Fabio Tirotta and TARPSWG collaborators👏 link below⬇️

We're launching a new series #fromCTOStoSUCCESS to highlight papers based on data presented at #CTOS2024!

🚨New benchmark values for outcomes of comprehensive resection of retroperitoneal liposarcoma! Great effort by <a href="/TirottaFabio/">Fabio Tirotta</a> and <a href="/TARPSWG/">TARPSWG</a> collaborators👏
link below⬇️
Patrick Schöffski (@schoffski) 's Twitter Profile Photo

Can hardly recall that I ever had 4 ongoing, actively recruiting, sarcoma-specific first in human Phase 1 trials at the same time. ADCs, bifunctional antibodies and novel kinase inhibitors - what a privilege, really can’t complain… Send your patients for these exclusive trials!

Can hardly recall that I ever had 4 ongoing, actively recruiting, sarcoma-specific first in human Phase 1 trials at the same time. ADCs, bifunctional antibodies and novel kinase inhibitors - what a privilege, really can’t complain… Send your patients for these exclusive trials!
Dr Sameer Rastogi (@samdoc_mamc) 's Twitter Profile Photo

Pleased to share Phase 2 trial results for low-dose regorafenib in relapsed synovial sarcoma. N=25, 76% previously exposed to pazopanib. 3-month progression-free rate: 56%. Median progression-free survival: 5 mths. ascopubs.org/doi/10.1200/GO… OncoDaily JCO Global Oncology

Pleased to share Phase 2 trial results for low-dose regorafenib in relapsed synovial sarcoma. 
N=25, 76% previously exposed to pazopanib. 3-month progression-free rate: 56%. Median progression-free survival: 5 mths. ascopubs.org/doi/10.1200/GO…
<a href="/oncodaily/">OncoDaily</a> <a href="/JCOGO_ASCO/">JCO Global Oncology</a>
Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

ADCs are rapidly improving the way we treat every type of cancer. Their potential has been largely unleashed over the past 6 years— yet their technology is the result of a 100-year long, epic journey. Join Raffaele Colombo & me to uncover 10 milestones in the development of ADCs (🧵):

nwsarcoma (@nwsarcoma) 's Twitter Profile Photo

Thank you to all the dads for all that you do. Your wisdom, your guidance and your hero status!! Happy Father's Day from all of us at NWSF. #sarcoma, #nwsarcoma, #dragonslayersunite

Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

China has now surpassed all other countries in number of new oncology clinical trials launched each year, AND also number of novel active substances (NAS) for cancers launched. IQVIA iqvia.com/library/videos…

China has now surpassed all other countries in number of new oncology clinical trials launched each year, AND also number of novel active substances (NAS) for cancers launched. <a href="/IQVIA_global/">IQVIA</a> 

iqvia.com/library/videos…
Annie Wong 黃毅敏 (@anmwongnz) 's Twitter Profile Photo

Exciting drug development scene in Asia-Pacific! Looking forward to engaging with colleagues from across the region in upcoming ESMO - Eur. Oncology Asia Targeted Anticancer Therapies meeting in HK. esmo.org/meeting-calend…

The EHE Foundation (@ehefoundation) 's Twitter Profile Photo

☝️ One Week Away: EHE Support Group Whether you're newly diagnosed or have been living with #EHE for a while, you’re not alone. Virtual EHE Support Groups are here to help you connect, reflect, and heal together. Register now to join us: fightehe.org/ehe-support-gr…

☝️ One Week Away: EHE Support Group
Whether you're newly diagnosed or have been living with #EHE for a while, you’re not alone. Virtual EHE Support Groups are here to help you connect, reflect, and heal together.

Register now to join us:
fightehe.org/ehe-support-gr…
Clinical Cancer Research (@ccr_aacr) 's Twitter Profile Photo

Clinical Cancer Research publishes innovative, high-impact clinical trials. Read the recently updated article collection: brnw.ch/21wTxxN

Clinical Cancer Research publishes innovative, high-impact clinical trials. Read the recently updated article collection: brnw.ch/21wTxxN
Patrick Schöffski (@schoffski) 's Twitter Profile Photo

The European Medicines Agency’s Committee for Medicinal Products has recommended granting marketing authorization for nirogacestat for the treatment of adults with progressing desmoid tumors. See also c.peerview.com/live/programs/…

Herbert Loong, MBBS, FASCO (@herbloong) 's Twitter Profile Photo

Always nice to reconnect with #friends and #colleagues from around the #world - some in real life for the very first time 😄. The global oncology is a small and close knit one 👍 Vivek Subbiah, MD #TinaCascone Sapna Patel FabriceAndre Charles Swanton Sherene Loi, MD and many others.

Always nice to reconnect with #friends and #colleagues from around the #world - some in real life for the very first time 😄. The global oncology is a small and close knit one 👍 

<a href="/VivekSubbiah/">Vivek Subbiah, MD</a> #TinaCascone <a href="/DrSapnaPatel/">Sapna Patel</a> <a href="/FAndreMD/">FabriceAndre</a> <a href="/CharlesSwanton/">Charles Swanton</a> <a href="/LoiSher/">Sherene Loi, MD</a> and many others.